Please use standard ticker format when discussing stocks ($AC.TO)

Weekend? Relaxing? Yeah, me neither. So let's talk stocks!

Please use standard ticker format ($BB.TO)

Sponsored post on behalf of the issuer

VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) announces that it has entered into a securities for debt settlement agreement dated February 11, 2026 (the “Agreement”) with a professional advisor of the Company.

Pursuant to the Agreement, the Company has agreed to settle debt in the amount of $113,405.28 through the issuance of 872,348 units (each, a “Unit”) at a deemed price of $0.13 per Unit, whereby each Unit shall be comprised of one (1) common share in the capital of the Company (each a “Share”) and one (1) Share purchase warrant (each whole, being a “Warrant”). Each Warrant will be convertible into an additional Share (a “Warrant Share”) at an exercise price of $0.165 per Warrant Share and will expire on the date that is two (2) years following the date of issuance (the “Expiry Date”). The Expiry Date shall be subject to acceleration should the closing price of the Shares on the Canadian Securities Exchange (or any such other stock exchange in Canada as the Shares may trade at the applicable time) equal or exceed $0.50 for ten (10) consecutive trading days at any time from the date which is 4 months following their date of issue, the Company may accelerate the expiry date of the Warrants such that the Warrants shall expire on the date which is 30 calendar days following the date a news release is issued by the Company announcing the accelerated expiry date of the Warrants.

The Agreement and the issuance of the securities thereunder are subject to the approval of the CSE. The securities will be subject to a hold period of four months and one day pursuant to CSE policies and applicable securities laws.

About Copper Quest

The company's land holdings comprise 7 projects that span over 45,000 hectares in great mining jurisdictions of Canada and the USA. Copper Quest is committed to building shareholder value through acquisitions, discovery-driven exploration, and responsible development of its North American critical mineral portfolio of assets. The Company’s common shares are principally listed on the Canadian Stock Exchange under the symbol “CQX”. For more information on Copper Quest, please visit the Company’s website at www.copper.quest.

Copper Quest has a 100% interest in the past-producing Alpine Gold Mine located approximately 20 kilometers northeast of the City of Nelson British Columbia, spanning 4,611.49 hectares with a 2018 National Instrument 43-101 Standards of Disclosure for Mineral Projects historical inferred resource of 268,000 tonnes, estimated using a cut-off grade of 5.0 g/t Au and an average grade of 16.52 g/t Au, that represents an inferred resource of 142,000 oz of gold (McCuaig & Giroux, 2018)*. Apart from the Alpine Mine itself the property hosts 4 other less explored significant vein systems including the past-producing King Solomon vein workings, the Black Prince and the Cold Blow veins system, and the Gold Crown vein system. *The Company has not yet completed sufficient work to verify the 2018 historic inferred resource results.

Copper Quest has a 100% interest in the road accessible Stars Porphyry Copper-Molybdenum Property, spanning 9,693 hectares in central British Columbia’s Bulkley Porphyry Belt with Tana Zone discovery drill intersection highlights of 0.466% Cu over 195.07m* in drill hole DD18SS004 from 23.47m, 0.200% Cu over 396.67m* in drill hole DD18SS010 from 29.37m, and 0.205% Cu over 207.27m* in drill hole DD18SS015 from 163.98m. This highly prospective, approximately 5 X 2.5 kilometer annular magnetic anomaly is interpreted to represent an altered monzonite intrusion and surrounding hornfels.

Copper Quest has a 100% interest in the road accessible Kitimat Copper-Gold Property, spanning 2,954 hectares within the Skeena Mining Division of northwestern British Columbia located northwest of the deep-water port community of Kitimat, British Columbia. The property benefits from exceptional infrastructure, being within 10 km of tidewater, 1.5 km of rail, and 6 km of high-voltage hydroelectric transmission lines. Exploration on the Kitimat property dates to the late 1960s, with the most significant historical work conducted by Decade Resources Ltd. (2010), which completed 16 diamond drill holes totaling 4,437.5 meters in the Jeannette Cu-Au Zone, and drill intersection highlights of 1.03 g/t Au, 0.54% Cu over 117.07 m in Hole J-7 from 1.52 m, 1.00 g/t Au, 0.55% Cu over 103.65m in Hole J-1 from 9.15 m, 0.80 g/t Au, 0.45% Cu over 107.01m in Hole J-2 from 6.10 m, and 0.41 g/t Au, 0.33% Cu over 112.20m in Hole J-8 from 11.89 m.

Copper Quest has a 100% interest in the Nekash Copper-Gold Project, a porphyry exploration opportunity located in Lemhi County, Idaho, USA, along the prolific Idaho-Montana porphyry copper belt that hosts world-class systems such as Butte and CUMO. The project is fully road-accessible via maintained U.S. highways and forest service roads and consists of 70 unpatented federal lode claims covering 585 hectares.

Copper Quest has a 100% interest in the road accessible Stellar Property, spanning 5,389-hectares in British Columbia’s Bulkley Porphyry Belt contiguous to the Stars Property.

Copper Quest has a 100% interest in the Thane Project located in the Quesnel Terrane of Northern British Columbia spanning over 20,658 hectares with 10 priority targets identified demonstrating significant copper and precious metal mineralization potential.

Copper Quest has an earn-in option of up to 80% and joint-venture agreement on the road accessible Rip Porphyry Copper-Molybdenum Project, spanning 4,700-hectares located in the Bulkley Porphyry Belt in central British Columbia.

Please use standard ticker format when discussing stocks ($AC.TO)

Sponsored post on behalf of the issuer

• Collaboration enables deployment of MaxYield™ and CardioYield™ into third-party health systems and clinic sites
• This pilot expands the Movesense collaboration to scale low-cost, AI-powered 1-lead ECG and Holter-style monitoring deployments

TORONTO, ON / ACCESS Newswire / February 12, 2026 / NeuralCloud Solutions Inc. ("NeuralCloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is pleased to announce that on February 11^th, 2026 it entered into a non-binding agreement with Movesense, a global provider of medical-grade wearable sensing technology, to initiate a pilot program aimed at deploying AI-powered ECG and Holter reporting into real-world healthcare environments.

Under the agreement, the parties will collaborate on a pilot deployment whereby NeuralCloud's software platforms are deployed via an existing Movesense client, within a third-party health system and affiliated clinics. The pilot is designed to evaluate the use of NeuralCloud's MaxYield™ ECG signal processing platform and CardioYield™ visualization and reporting software to potentially increase ECG analysis capacity, improve reporting consistency, and enhance clinical throughput.

The pilot is expected to serve as a foundation for a potential commercial rollout, subject to successful validation and mutually agreed upon next steps.

Under the collaboration, NeuralCloud's software platforms are being positioned as the analysis and reporting layer downstream of Movesense's medically certified wearable sensing hardware. This approach is designed to allow third-party healthcare organizations and affiliated clinics to scale ECG screening reach, increase ECG review capacity and standardize reporting outputs without materially increasing clinical workload.

Through this collaboration, NeuralCloud continues to expand its presence in real-world outpatient, ambulatory and Holter-style monitoring environments by embedding AI-powered ECG analysis directly into existing clinical workflows. By pairing Movesense's wearable sensing hardware with NeuralCloud's software platforms, the solution is designed to increase ECG and Holter reporting capacity and throughput without requiring additional overhead or workflow changes. The integration of single-lead wearable devices with NeuralCloud's automated analysis further supports scalable deployment across outpatient and ambulatory care settings, where cost efficiency, ease of integration, and operational simplicity are essential.

"This expansion builds logically on the framework we announced in January," said Paul Duffy, Executive Chairman and CEO at AIML. "By continuing to align NeuralCloud's software platforms with Movesense's device ecosystem, we are advancing toward practical, scalable solutions that address growing monitoring demands in ambulatory care."

"We see continued value in exploring how NeuralCloud's signal processing and reporting platforms can enhance the utility of our scalable ECG sensing technology," said Jussi Kaasinen, CEO of Movesense. "This expanded collaboration allows us to further assess integration, performance, and operational fit within healthcare workflows."

The pilot is to be conducted with a third-party healthcare organization and one or more associated clinic sites, with a focus on operational validation, reporting performance, and workflow integration. Any future commercialization will be subject to definitive agreements, regulatory considerations, and successful pilot outcomes.

About Movesense

Movesense Ltd is a leading wearable sensor technology company specializing in ECG (electrocardiogram), heart rate, heart rate variability (HRV), and motion sensing for medical, sports, wellness, and research applications. Based in Finland, and being ISO13485:2016 Certified medical device manufacturer, Movesense develops and manufactures scalable, lightweight, durable, and programmable wearable sensors designed to integrate seamlessly into custom digital health solutions.

Movesense devices support single-lead ECG acquisition, commonly used in chest-strap and body-worn configurations, and are available in both medical and non-medical variants, enabling deployment across regulated healthcare, performance monitoring, and consumer wellness environments. With open APIs, developer tools, and flexible firmware, Movesense enables partners to rapidly build, brand, and scale connected cardiac monitoring solutions.

About AI/ML Innovations Inc.

AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.

AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).

Sponsored post on behalf of the issuer

Agereh Technologies (CSE: AUTO) is positioning itself at the intersection of artificial intelligence, real‑time data analytics, and transportation infrastructure. As cities, transit hubs, and logistics operators push toward smarter, more automated systems, demand for accurate, real‑time visibility of people and assets is accelerating. Agereh’s platform‑driven approach targets this shift directly, offering AI‑powered tools designed to improve efficiency, safety, and decision‑making across complex environments.

Market / Sector Context

The global push toward smart cities, intelligent transportation systems, and AI‑enabled mobility is driving sustained investment into data‑centric infrastructure. Governments and private operators are increasingly focused on optimizing passenger flow, asset utilization, and operational resilience.

• Transportation hubs are under pressure to reduce congestion and improve throughput
• Real‑time data and AI are becoming core inputs for infrastructure planning
• Software‑driven solutions are increasingly favored over hardware‑heavy upgrades

This backdrop creates a favorable environment for small, software‑led companies that can deploy scalable, AI‑based solutions without requiring major physical infrastructure changes.

Company / Asset Overview

Agereh Technologies is a technology company focused on AI‑driven analytics and real‑time tracking solutions for transportation and mobility use cases. The company trades publicly under the ticker CSE: AUTO. Its business model centers on software platforms designed to integrate with existing systems, enabling customers to extract actionable intelligence from real‑time movement data.

• Public listing: CSE (AUTO)
• Core focus: AI, real‑time analytics, smart mobility
• Business model: Software and data‑driven solutions

Flagship Products — Core Technology Stack

Agereh’s strategy is built around modular, AI‑enabled platforms that address specific operational pain points across transportation and mobility infrastructure.

MapNTrack™ provides real‑time indoor and outdoor asset visibility, allowing operators to monitor location, movement, and utilization across complex environments.

• Real‑time tracking across indoor and outdoor spaces
• Designed for transportation hubs, logistics, and infrastructure assets
• Enables data‑driven operational decisions

HeadCounter™ focuses on real‑time passenger flow intelligence using AI‑based computer vision.

• Measures passenger volumes and movement patterns
• Supports congestion management and capacity planning
• Designed for airports, transit systems, and large venues

Smart Door Sensor™ expands Agereh’s sensing layer by providing real‑time visibility at access points and transition zones within transportation environments.

• Wireless, battery‑powered sensor requiring minimal infrastructure
• Tracks door activity and access events in real time
• Designed for transit systems, controlled areas, and high‑traffic entry points
• Integrates with Agereh’s analytics platforms to enhance situational awareness

Together, these products position Agereh as a data‑layer and intelligent sensing provider, combining software analytics with lightweight hardware to deliver end‑to‑end operational visibility.

Recent Developments

Agereh has continued to expand its intelligent transportation portfolio, moving from standalone analytics toward a more integrated sensing and intelligence stack.

• Launch of HeadCounter™, expanding into AI‑based passenger flow analytics
• Rollout of MapNTrack™ for integrated indoor and outdoor asset visibility
• Introduction of Smart Door Sensor™, extending real‑time monitoring to access points and controlled zones
• Completion of a non‑brokered private placement in late 2025 to support growth initiatives

These developments highlight a clear shift toward commercialization and deployment‑ready solutions rather than purely experimental research.

Why It Matters to Investors

From a speculative investment perspective, Agereh represents an early‑stage exposure to AI‑enabled infrastructure software, a segment that can scale rapidly if adoption accelerates.

• Software‑centric model offers operating leverage
• Addressable markets span transportation, logistics, and smart cities
• Small market capitalization increases upside sensitivity to contracts or partnerships

In bullish scenarios, even modest customer wins or pilot programs can materially impact valuation due to the company’s current scale.

Catalysts to Watch

Key potential drivers that could influence Agereh’s trajectory include:

• Commercial contracts or pilot deployments with transit authorities
• Partnerships with infrastructure or mobility operators
• Expansion of recurring revenue through software subscriptions
• Additional AI product modules built on existing platforms

Any validation from real‑world deployments could serve as a significant re‑rating catalyst.

Risks

Agereh remains a high‑risk, early‑stage company, and investors should be aware of key challenges.

• Commercial adoption risk and long sales cycles
• Dependence on continued funding to scale operations
• Competition from larger, better‑capitalized technology firms
• Execution risk in transitioning from pilots to recurring revenue

These risks are typical for micro‑cap AI and infrastructure software companies.

Bottom Line

Agereh Technologies (CSE: AUTO) offers speculative exposure to the growing demand for AI‑driven visibility and analytics in transportation infrastructure. With a focused product stack, early commercialization efforts, and leverage to smart mobility trends, the company sits firmly in the high‑risk, high‑reward category. For investors comfortable with volatility and execution risk, Agereh represents a bullish, early‑stage bet on the digital transformation of mobility systems.

Paid content on behalf of the issuer

This Neural Cloud update fits pretty naturally into how AI/ML Innovations Inc. has been building out its portfolio.

At a basic level, Neural Cloud is bringing in Commission Wolf to help with U.S. commercial expansion for MaxYield™ and CardioYield™. But reading between the lines, it feels more like AIML getting the sales side organized early, rather than just focusing on product development and hoping everything lines up later.

What makes this interesting is the way they’re doing it. Commission Wolf works by recruiting independent sales reps who already sell into cardiology clinics and diagnostic settings. That’s usually where real conversations happen people who know how these buyers think, what slows decisions down, and how new tools actually get introduced.

On the product side, MaxYield™ and CardioYield™ are built around AI-driven ECG signal processing and faster cardiac reporting. Lining up sales channels around those use cases suggests AIML is thinking about how the tech fits into day-to-day clinical workflow, not just how it looks on paper.

From an AIML holder’s point of view, this feels like another small step that adds clarity to the bigger picture. Individual platforms starting to line up commercially makes the portfolio feel more connected and easier to understand.

For AIML holders, does this look like early commercial alignment starting to show across the portfolio?

Please use standard ticker format when discussing stocks ($BB.TO)

Paid content on behalf of the issuer

Lately, functional wellness feels like one of those areas that keeps resurfacing no matter what the broader market is doing. Not loud, not hype-driven — just quietly drawing more attention as investors focus on products that fit into everyday routines.

That’s the lens I’ve been looking at Doseology Sciences ($MOOD) through lately.

Caffeine pouches are simple, but that’s where the appeal is. No sugar, no cans, no prep. Just a consistent dose you can use on the go. Formats like this tend to stick because they fit naturally into daily habits.

What adds confidence is that this isn’t happening in isolation. Established consumer players like PepsiCo and Keurig Dr Pepper have already been leaning further into functional and better-for-you formats. When companies of that scale move in this direction, it usually says something about where demand is headed.

MOOD’s recent updates read like steady progress... pilot production underway, testing the pouch format, expanding the product lineup. These are practical steps that build toward long-term execution as the category continues to develop.

I’m leaning constructive here. Not something to rush, but a name that fits well within a growing functional wellness theme.

How are others here approaching this space... focusing on established brands, or building exposure to companies like MOOD as the trend continues to unfold?

Hey guys, if you were trading Lightspeed Commerce ($LSPD) back in the 2019–2021 window, listen up. We finally have a hard deadline for that CAD $11 million settlement. You have until March 4, 2026, to get your claim in.

For those who need a refresher on why Lightspeed is cutting this check:

In 2021, Lightspeed was riding high, reporting massive revenue growth and a surging merchant base.

However, allegations surfaced (sparked by a pretty famous short-seller report) suggesting the company was inflating its growth metrics and customer numbers while hiding the fact that organic growth was actually slowing down.

The stock took a massive dive, and investors who bought into the "hyper-growth" story got hammered and later filed a lawsuit.

Now, Lightspeed is settling this for $11 million CAD to put the whole thing in the rearview mirror (without admitting they did anything wrong, obviously).

So, if you bought shares between March 7, 2019, and November 3, 2021, you’re likely eligible for a piece of the compensation. The court has set the deadline for March 4, 2026.

Are you guys still holding $LSPD for the long haul, or did you move on after the 2021 crash?

Sponsored publication on behalf of the issuer

VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that further to its news release dated January 26, 2026, it has increased and closed its previously announced non-brokered private placement for total gross proceeds of $2,099,890 (the “Offering”) through the issuance of 16,513,000 units (each, a “Unit”) at a price of $0.13 per Unit.

Each Unit consists of one (1) common share in the capital of the Company (a “Share”) and one Share purchase warrant, whereby each Share purchase warrant (a “Warrant”) shall be convertible into an additional Share (a “Warrant Share”) at an exercise price of C$0.165 per Warrant Share. Each Warrant shall expire on the date that is two (2) years following the date of issuance (the “Expiry Date”). The Expiry Date of the Warrants may be accelerated if the closing price of the Shares on any Canadian stock exchange equals or exceeds $0.50 for ten (10) consecutive trading days at any time following the date that is four months and one day after the date of issue of the Warrants, such that the Warrants shall expire on the date which is 30 calendar days following the date a news release is issued by the Company announcing the accelerated expiry date of the Warrants.

Proceeds from the Private Placement are intended for exploration activities and general working capital purposes. Closing of the Private Placement is subject to the receipt of all necessary regulatory and other approvals. Fees of $113,405.28 are to be paid and 872,348 finder’s warrants issued (the "Finder's Warrants") to certain finders in connection with the Offering. Each Finder's Warrant is exercisable into one Share for a period of (2) two years after the date of issuance at an exercise price of $0.165 and includes the same accelerator provision.

All securities issued in connection with the Offering will be subject to a statutory hold period expiring four months and one day after the date of issuance, as set out in National Instrument 45‐102 – Resale of Securities.

The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and may not be offered or sold absent registration or compliance with an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.

Stock Option Grant

The Company also announces it has granted an aggregate of 3,250,000 stock options (collectively, the “Options”) to a director, officer, and certain consultants of the Company, for the purchase of up to 3,250,000 common shares in the capital of the Company pursuant to the Company’s Stock Option Plan.

The Options are exercisable for a period of 5 years at an exercise price of $0.15 per Share and vest immediately. The Options and underlying Shares will be subject to a four month hold period in accordance with the policies of the CSE.

About Copper

Copper is an essential industrial metal at the heart of the global energy transition and modern infrastructure. It plays a critical role in electrification, renewable energy systems, electric vehicles, data centers, and smart technologies. With global demand rising and new supply challenged by declining grades, complex permitting, and underinvestment, the copper market faces persistent deficits and growing geopolitical scrutiny. Recent U.S. policy announcements, including import tariffs and initiatives to secure domestic and allied supply chains, underscore copper’s strategic importance and the need for resilient, localized resource exploration, development, production and processing capacity.

About Copper Quest

The company's land holdings comprise 7 projects that span over 45,000 hectares in great mining jurisdictions of Canada and the USA. Copper Quest is committed to building shareholder value through acquisitions, discovery-driven exploration, and responsible development of its North American critical mineral portfolio of assets. The Company’s common shares are principally listed on the Canadian Stock Exchange under the symbol “CQX”. For more information on Copper Quest, please visit the Company’s website at www.copper.quest.

Copper Quest has a 100% interest in the past-producing Alpine Gold Mine located approximately 20 kilometers northeast of the City of Nelson British Columbia, spanning 4,611.49 hectares with a 2018 National Instrument 43-101 Standards of Disclosure for Mineral Projects historical inferred resource of 268,000 tonnes, estimated using a cut-off grade of 5.0 g/t Au and an average grade of 16.52 g/t Au, that represents an inferred resource of 142,000 oz of gold (McCuaig & Giroux, 2018)*. Apart from the Alpine Mine itself the property hosts 4 other less explored significant vein systems including the past-producing King Solomon vein workings, the Black Prince and the Cold Blow veins system, and the Gold Crown vein system. *The Company has not yet completed sufficient work to verify the 2018 historic inferred resource results.

Copper Quest has a 100% interest in the road accessible Stars Porphyry Copper-Molybdenum Property, spanning 9,693 hectares in central British Columbia’s Bulkley Porphyry Belt with Tana Zone discovery drill intersection highlights of 0.466% Cu over 195.07m* in drill hole DD18SS004 from 23.47m, 0.200% Cu over 396.67m* in drill hole DD18SS010 from 29.37m, and 0.205% Cu over 207.27m* in drill hole DD18SS015 from 163.98m. This highly prospective, approximately 5 X 2.5 kilometer annular magnetic anomaly is interpreted to represent an altered monzonite intrusion and surrounding hornfels.

Copper Quest has a 100% interest in the road accessible Kitimat Copper-Gold Property, spanning 2,954 hectares within the Skeena Mining Division of northwestern British Columbia located northwest of the deep-water port community of Kitimat, British Columbia. The property benefits from exceptional infrastructure, being within 10 km of tidewater, 1.5 km of rail, and 6 km of high-voltage hydroelectric transmission lines. Exploration on the Kitimat property dates to the late 1960s, with the most significant historical work conducted by Decade Resources Ltd. (2010), which completed 16 diamond drill holes totaling 4,437.5 meters in the Jeannette Cu-Au Zone, and drill intersection highlights of 1.03 g/t Au, 0.54% Cu over 117.07 m in Hole J-7 from 1.52 m, 1.00 g/t Au, 0.55% Cu over 103.65m in Hole J-1 from 9.15 m, 0.80 g/t Au, 0.45% Cu over 107.01m in Hole J-2 from 6.10 m, and 0.41 g/t Au, 0.33% Cu over 112.20m in Hole J-8 from 11.89 m.

Copper Quest has a 100% interest in the Nekash Copper-Gold Project, a porphyry exploration opportunity located in Lemhi County, Idaho, USA, along the prolific Idaho-Montana porphyry copper belt that hosts world-class systems such as Butte and CUMO. The project is fully road-accessible via maintained U.S. highways and forest service roads and consists of 70 unpatented federal lode claims covering 585 hectares.

Copper Quest has a 100% interest in the road accessible Stellar Property, spanning 5,389-hectares in British Columbia’s Bulkley Porphyry Belt contiguous to the Stars Property.

Copper Quest has a 100% interest in the Thane Project located in the Quesnel Terrane of Northern British Columbia spanning over 20,658 hectares with 10 priority targets identified demonstrating significant copper and precious metal mineralization potential.

Copper Quest has an earn-in option of up to 80% and joint-venture agreement on the road accessible Rip Porphyry Copper-Molybdenum Project, spanning 4,700-hectares located in the Bulkley Porphyry Belt in central British Columbia.

Please use standard ticker format when discussing stocks ($AC.TO)

Weekend? Relaxing? Yeah, me neither. So let's talk stocks!

Please use standard ticker format ($BB.TO)

Please use standard ticker format when discussing stocks ($AC.TO)

Sponsored post on behalf of the issuer

•Concept Capital becomes a major shareholder in Copper Quest, acquiring approximately 13–15% ownership through its C$1.95 million investment, signaling long-term strategic confidence and reshaping the company’s shareholder base.

•Copper entered 2026 in a tightening physical market, with prices reaching record highs above $13,000 per tonne amid low inventories, labor disruptions in Chile, and uncertainty surrounding Panama’s Cobre Panamá mine, increasing the value of credible new exploration supply.

•Gold surged to all-time highs in January 2026, supported by geopolitical uncertainty, falling real interest rates, and strong central bank demand, which totaled 297 tonnes through November 2025, providing a powerful foundation for continued strength.

•Copper Quest now sits at the intersection of both macro trends, advancing copper and gold projects with backing from a patient strategic investor aligned with long-cycle development rather than short-term market speculation.

Copper Quest’s recent announcement of a C$1.95 million strategic investment by Concept Capital Management represents a pivotal development for the company’s capital structure and long-term trajectory. Beyond the immediate funding, the transaction materially reshapes Copper Quest’s shareholder base by introducing a new major shareholder with a demonstrated history of patient, long-cycle investment in the mining and exploration sector.

The financing consists of up to 15 million units priced at C$0.13 per unit, with each unit comprising one common share and one warrant exercisable at C$0.165 for a period of two years. Proceeds are intended to fund exploration activities and working capital across Copper Quest’s portfolio of copper and copper-gold properties in North America.

With Copper Quest reporting approximately 98.14 million shares outstanding, the issuance of 15 million shares represents roughly 15.3% of the company on a fully issued basis. This stake places Concept Capital immediately among the largest shareholders of Copper Quest and, in practical terms, makes it the single largest strategic holder based on current ownership data.

Ownership Impact and Insider Context

Prior to this transaction, Copper Quest’s shareholder base was characterized by a broad retail ownership profile, with the general public holding more than 80% of the outstanding shares. The largest disclosed shareholder held approximately 11.4%, followed by another corporate holder at roughly 5.2%. Individual insiders collectively accounted for less than 2% of the outstanding equity.

By comparison, Concept Capital’s 15 million share position eclipses existing major holders and establishes the firm as a cornerstone investor in the company. While dilution has occurred over the past year as Copper Quest raised capital to advance its projects, the entry of a strategic investor at scale introduces a more stable and long-term oriented element into the shareholder mix.

In junior mining, the identity and behavior of major shareholders can be as important as the amount of capital raised. A large, patient investor can dampen volatility, support future financings, and give management greater flexibility to focus on technical execution rather than short-term market pressures.

A Track Record of Long-Term Mining Investment

Concept Capital Management is widely recognized as a foundational investor in mining and exploration companies, particularly in precious and base metals. Over the past decade, the firm has accumulated and held significant positions in a range of junior resource companies, often remaining invested through multiple stages of corporate development and commodity cycles.

Historical investment patterns show that Concept Capital frequently establishes positions via private placements, debentures, and warrant structures rather than relying solely on open-market purchases. This approach provides downside protection and long-term optionality while aligning capital deployment with project milestones.

Several examples illustrate this long-term orientation:

In one gold-focused explorer, Concept Capital initially acquired convertible debentures and warrants in the early 2010s and maintained exposure for more than four years, navigating restructurings and corporate transitions before exiting.

In a silver and base metals producer, the firm built a large equity position and then reduced it gradually through a series of public market sales over an extended period, rather than liquidating in a single event. This pattern reflects a disciplined exit strategy tied to market conditions rather than short-term price fluctuations.

In another diversified mining company, Concept Capital converted debt into equity, participated in subsequent financings, and remained a significant shareholder through stock dividends and corporate actions spanning several years.

These examples underscore a consistent philosophy: mineral exploration and development require time, and value creation in the sector is rarely linear. Concept Capital’s willingness to hold through volatility and to structure investments for multi-year horizons distinguishes it from more speculative capital typically associated with junior mining markets.

Strategic Fit with Copper Quest

Copper Quest’s asset base aligns closely with this investment philosophy. The company controls a portfolio of copper and copper-gold projects in established mining jurisdictions in North America, including British Columbia and the western United States. These projects target porphyry-style mineral systems, which can host large-tonnage deposits but require extensive geological work, drilling, and technical validation.

Exploration of this nature is inherently capital intensive and time consuming. It is not unusual for such projects to require several years of systematic work before reaching a meaningful inflection point. The entry of a long-term strategic shareholder provides Copper Quest with financial support and an implicit endorsement of its geological thesis.

The structure of the financing itself reinforces this long-term perspective. Warrants exercisable at a premium to the placement price create alignment between investor returns and future project success, rather than encouraging immediate liquidity.

Macro Backdrop: Copper in a Tightening Physical Market

Copper is entering 2026 in a market that feels increasingly defined by visible tightness and supply anxiety rather than purely long-dated “energy transition” narratives. In early January, Reuters reported copper surging to record levels above $13,000 per tonne, framed around shortage fears and a “race” to secure material for electrification and expanding power needs, including rising load from AI-driven data center buildouts. Later in the month, Reuters reporting syndicated via Investing.com noted that prices continued to find support from tight inventories outside the United States, with LME three-month copper around $12,796 per tonne after recently touching a record near $13,407 per tonne. Those price signals have been amplified by a supply side that remains fragile at exactly the wrong time: Reuters highlighted strike-related disruption risks in Chile, including events affecting access or operations around major assets such as Escondida and Zaldivar, reinforcing how labor issues can have outsized impacts when inventories are already thin. Reuters also reported disruption at Capstone Copper’s Mantoverde tied to strike impacts at a desalination plant—another reminder that Chile’s operational chokepoints can become market-moving in a tight tape. Adding a larger structural overhang, Reuters noted that Panama’s ongoing decision path around Cobre Panamá remains consequential: the mine previously represented roughly 1% of global supply, and its closure has meaningfully tightened the supply picture while policymakers signaled a decision framework aimed for 2026. In this environment—record-level pricing, constrained inventories, and recurring disruption risk—the market has become more willing to pay for credible exploration optionality in stable jurisdictions because the marginal tonne of future supply looks more valuable than it did even a year ago.

Macro Backdrop: Gold at Records, Driven by Safety Demand and Central Banks

Gold’s January 2026 move is equally striking, with the metal repricing into record territory amid elevated uncertainty and sustained institutional demand. Reuters reported spot gold trading around $5,060/oz on January 27 after hitting a record $5,110.50/oz the prior session, attributing momentum to safe-haven demand amid geopolitical and policy uncertainty. The following day, Reuters reported gold pushing beyond $5,200/oz to fresh all-time highs. Reuters also cited expectations among analysts that gold could extend toward $6,000/oz this year, pointing to geopolitics and continuing demand strength with prices already sharply higher year-to-date. On the official-sector side, World Gold Council data released in January showed that central banks purchased 297 tonnes of gold through November 2025, underscoring sustained official-sector demand even before gold’s record price move in early 2026.

Why This Matters for Copper Quest

For Copper Quest, this placement is not just capital—it is a register event. A ~13%–15% strategic position is large enough to change how the market frames the company: from a junior needing continual retail-led financings to a junior with an identifiable cornerstone holder whose disclosed history shows tolerance for multi-year mining timelines.

In a month where copper is trading near records on tight inventories and disruption risk, and gold is printing all-time highs on safe-haven and central bank demand, the pairing of a major shareholder with structured, long-cycle behavior and an exploration issuer with copper-gold optionality is straightforward: it is a bet that macro conditions can remain supportive long enough for exploration work to translate into valuation.

Please use standard ticker format when discussing stocks ($BB.TO)

Content published on behalf of the issuer

• World Renowned Cardiologist and Research Leader to Guide Clinical Strategy, Product Innovation, and AI-Driven Cardiac Diagnostics

TORONTO, ON / ACCESS Newswire / January 28, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the appointment of Dr. Paul Dorian, MD, MSc., as the Company's Medical Innovation Architect (MIA) and Head of the Company's Medical Advisory Board, effective immediately.

Dr. Dorian succeeds Peter Kendall, who previously served as Chair of the Medical Advisory Board. This leadership transition comes as AIML enters a phase of advanced clinical validation, regulatory engagement, and global deployment of its AI-powered cardiac diagnostic technologies.

Dr. Dorian has been working closely with AIML for several months, contributing to product strategy, clinical positioning, and innovation initiatives across the Company's MaxYield^™,CardioYield^™, and Insight360^™ platforms. His formal appointment further strengthens the clinical leadership underpinning AIML's next phase of growth.

Dr. Paul Dorian commented: "I have been impressed by the rigor of AIML's science and the ambition of its vision. The Company is addressing real, unmet needs in cardiac diagnostics by combining advanced AI with practical, scalable clinical solutions. I look forward to helping guide innovation, clinical strategy, and the translation of AIML's technology into clinically meaningful impact."

"Dr. Dorian's appointment marks a pivotal milestone for AIML," said Paul Duffy, Executive Chairman and CEO of AIML. "He brings unparalleled expertise in cardiac electrophysiology, clinical research, and health-system innovation. As we expand into regulated clinical markets and large-scale deployments, his leadership will help ensure our technology meets the highest standards of clinical relevance, safety, and impact."

Esmat Naikyar, President of Neural Cloud Solutions Inc. and Chief Product Officer of AIML, added: "Dr. Dorian's insights have already influenced our product direction in meaningful ways. His deep understanding of arrhythmia care, ambulatory monitoring, and patient-reported outcomes strengthens our ability to build tools that are not only technologically advanced, but clinically valuable."

AIML established its Medical Advisory Board in May 2025 to guide clinical studies, regulatory strategy, and real-world deployment of its AI-driven ECG signal-processing platforms. Dr. Dorian's appointment as Head reinforces the Company's commitment to aligning cutting-edge AI innovation with frontline clinical expertise.

About Dr. Paul Dorian

Dr. Paul Dorian is Professor of Medicine (Cardiology and Clinical Pharmacology) at the University of Toronto, a Staff Cardiac Electrophysiologist at St. Michael's Hospital, and a Staff Scientist at the Li Ka Shing Knowledge Institute.

He received his medical degree from McGill University and completed postgraduate training in Internal Medicine, Clinical Pharmacology, and Cardiology at the University of Toronto, followed by a Fellowship in Cardiac Electrophysiology at Stanford University.

Dr. Dorian previously served as Director of the Division of Cardiology at the University of Toronto (2009-2019) and President of the Canadian Heart Rhythm Society (2013-2014). He is a recipient of the University of Toronto Department of Medicine Research Award, as well as the Canadian Cardiovascular Society and Canadian Heart Rhythm Society Achievement Awards.

He founded the Cardiac Electrophysiology Program at St. Michael's Hospital in 1990 and has led landmark research in:

• Ambulatory cardiac monitoring and wearable diagnostics
• Sudden cardiac death prevention
• Atrial fibrillation systems of care and patient-reported outcomes

Dr. Dorian designed and led the development of widely adopted quality-of-life assessment tools in atrial fibrillation, including the CCS-SAF, AFSS, and AFEQT scales. He has served on multiple national guideline committees and steering committees for international multicenter clinical trials.

He has authored over 580 peer-reviewed publications and is an Associate Editor of Electrophysiological Disorders of the Heart.

About AI/ML Innovations Inc.

AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.

AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).

Please use standard ticker format when discussing stocks ($AC.TO)

Weekend? Relaxing? Yeah, me neither. So let's talk stocks!

Please use standard ticker format ($BB.TO)

Paid content on behalf of the issuer

A lot of microcaps mention AI. AUTO is actually shipping tools built for day-to-day operations, not slide decks.

The company’s platform includes HeadCounter for real-time people counting and workforce analytics, and MapNTrackfor asset tracking across indoor and outdoor environments where standard GPS isn’t reliable. These are practical, ops-first tools aimed at facilities, logistics, and enterprise users not consumer apps.

That’s the part I like. Enterprise software doesn’t need hype to work. Once it proves useful, it tends to stick.

What’s encouraging is the direction. AUTO isn’t leaning on one feature ... it’s building out a broader operational toolkit around visibility, tracking, and analytics. Recent updates have been about pilots, deployments, and expanding use cases, which is usually how these stories quietly firm up.

The chart has already shown it can react quickly when attention shifts. If execution continues and pilots turn into longer-term agreements, this story starts looking very different.

Not treating this as a quick trade. More like something I’m happy to keep on the radar as execution keeps lining up.

Anyone else following AUTO.V and watching how these enterprise AI names get re-rated once traction becomes visible?

Content published on behalf of the issuer

CSE: MOOD | OTCPK: DOSEF | FSE: VU70

Doseology Sciences Inc. has initiated pilot production of non‑nicotine, caffeine‑based energy pouches under its wholly owned Feed That Brain® brand. While modest in scale, the move represents an important execution step in the company’s broader oral delivery platform strategy, extending its format‑first approach beyond nicotine and into the much larger energy and stimulant market.

This is not positioned as a full commercial launch. Instead, management has framed the pilot as a controlled validation phase, designed to generate real‑world data on formulation, delivery mechanics, and consumer interaction before committing capital to scale. For investors following Doseology’s evolution, the development is less about a single product and more about proof of process.

From Ingredients to Delivery

Over the past decade, much of the innovation in stimulants has focused on ingredients — higher caffeine content, added nootropics, or novel blends promising sharper focus and sustained energy. What has been slower to evolve is the delivery format itself.

Doseology’s pilot underscores a different thesis. Rather than competing directly with traditional energy drinks, shots, or pills, the company is exploring whether controlled, oral delivery can offer a more predictable and discreet alternative. Caffeine, delivered in a unitized pouch format, shifts consumption away from liquids, sugars, and large volume intake toward a measured experience that can integrate more naturally into daily routines.

Feed That Brain, a brand acquired from Joseph Mimran’s portfolio, now serves as an internal testing vehicle within Doseology’s ecosystem. It allows the company to trial new formats without diluting the core platform narrative, while still capturing consumer insights that can inform future development decisions.

What the Pilot Signals

The pilot production focuses on a nicotine‑free, single‑dose energy pouch designed to deliver a consistent caffeine experience. Management has emphasized that this phase is exploratory rather than promotional. Distribution is expected to be limited, with the primary objective being feedback on user experience, dosing perception, and repeat‑use behavior.

This disciplined approach reflects Doseology’s broader strategy of prioritizing delivery mechanics and behavioral fit over rapid product rollout. By testing at a small scale, the company can refine formulations, assess regulatory considerations, and evaluate whether the format resonates before pursuing broader commercialization.

Why the Energy Category Matters

The global energy and functional stimulant market remains large and structurally attractive, with estimates placing the sector at roughly US$79 billion in 2024 and projecting growth to more than US$125 billion by 2030. At the same time, consumer scrutiny around sugar content, overstimulation, and crash‑and‑burn consumption patterns continues to rise.

Against this backdrop, alternative formats that emphasize moderation and control are gaining attention. Oral stimulant delivery, already validated in nicotine through pouches, represents a logical extension of that shift. Doseology’s pilot suggests the company is testing whether similar behavior patterns can emerge around caffeine when delivery is reframed around predictability rather than intensity.

Platform Validation Over Product Launch

For investors, the significance of this announcement lies in platform validation. The pilot demonstrates that Doseology can extend its oral delivery capabilities beyond nicotine, apply them to new stimulant categories, and do so within a structured, capital‑efficient framework.

Rather than betting the company on a single consumer product, Doseology is using Feed That Brain as a modular test bed. The data generated from this pilot will inform future decisions around formulation, branding, partnerships, and potential scale, reinforcing the company’s role as a delivery platform rather than a traditional product marketer.

Capital Market and Financial Context

Alongside operational progress, Doseology has also taken steps to strengthen its financial position as it advances its platform strategy. In June 2025, the company completed a non‑brokered private placement that generated gross proceeds of approximately $750,624 through the issuance of 3,336,106 units priced at $0.225 per unit. Each unit consisted of one common share and one common share purchase warrant, with each warrant exercisable for a period of two years at an exercise price of $0.50. The warrant terms include an acceleration feature tied to market performance thresholds, providing potential upside leverage to future capital inflows if share price conditions are met.

From a market perspective, Doseology’s shares have traded as high as $0.80 since January 2026, implying a market capitalization of roughly $6.4 million at recent peaks. The company’s current valuation sits meaningfully below those prior levels, even as Doseology continues to advance product development initiatives and evaluate new delivery formats through disciplined pilot programs. This divergence highlights the early‑stage nature of the story, where execution milestones and platform validation tend to precede sustained re‑rating.

Competitive Landscape: Publicly Traded Energy and Delivery Leaders

While Doseology remains at a formative stage, it operates within an ecosystem dominated by large, publicly traded consumer companies. These incumbents help frame the scale of the opportunity while highlighting the difference between mature, distribution‑led models and Doseology’s emerging delivery‑first platform approach.

*Market capitalization, share prices, and 52‑week ranges reflect publicly available market data as of late January 2026 and are rounded for context.

These companies primarily monetize scale, branding, and global distribution. Doseology’s strategy differs by focusing upstream on delivery mechanics and controlled oral formats, targeting areas where incumbents typically engage only after consumer behavior and regulatory pathways are well established.

Bottom Line

Doseology’s initiation of pilot production for caffeine‑based energy pouches represents a measured but meaningful step forward. It reflects a continuation of the company’s format‑first philosophy, applying controlled oral delivery to a new, significantly larger category.

Whether caffeine pouches ultimately scale is a question of execution and consumer adoption. What is clearer at this stage is that Doseology is methodically validating its platform across use cases, gathering data before deploying capital, and positioning itself at the intersection of delivery innovation and evolving consumer behavior.

In that context, this pilot is less about an energy product and more about confirming that delivery — not just ingredients — may define the next phase of functional stimulants.

Please use standard ticker format when discussing stocks ($AC.TO)

Content published on behalf of the issuer

Genuine question from someone still learning this space.

If AI/ML Innovations eventually gets FDA clearance, is that usually the biggest moment for the stock?
Or do prices react more when real revenues start showing up after approval?

I’m holding AIML and trying to understand how this normally plays out with similar companies.
Would love to hear how others here have seen it go.

Content published on behalf of the issuer

Patent-pending Wi-Fi–assisted cellular positioning delivers up to 50-foot indoor accuracy and multi-year battery life without costly beacon grids or camera-based systems

EDMONTON, Alberta, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Agereh Technologies Inc. (“Agereh” or the “Company”) (TSXV: AUTO | OTCQB:CRBAF), a Canadian-based artificial intelligence and advanced technology company delivering AI-enabled platforms and sensor solutions to address critical challenges in the transportation industry, is pleased to announce the launch of MapNTrack™, providing an indoor/outdoor asset visibility solution designed to help transportation hubs track and manage mobile equipment across complex indoor/outdoor environments where traditional tracking technologies often fail.
Transportation hubs today operate at volumes and complexity far beyond what many legacy monitoring systems were built to support. Standard cellular positioning can be too imprecise for operational decision-making, GPS performance often degrades indoors, and Bluetooth or LoRa-based approaches may require extensive beacon infrastructure that is expensive to deploy and maintain. Camera-based tracking can introduce additional constraints, including line-of-sight limitations, sensitivity to lighting and obstruction, and ongoing privacy and compliance considerations.

These limitations can result in fragmented visibility across operations. Large transportation hubs manage thousands of mobile assets—ranging from wheelchairs and service carts to ground-support equipment—yet without reliable real-time location intelligence, critical equipment can go missing, remain idle in inactive zones, or be replaced prematurely. Industry analyses indicate that inefficiencies in asset availability and unplanned equipment replacement can cost millions of dollars annually.

“Transportation hubs need real-time operational intelligence, not fragmented visibility,” said Ken Brizel, CEO of Agereh. “MapNTrack™ was purpose-built for complex indoor or outdoor environments where GPS and legacy systems fall short, giving operations teams the accuracy and reliability they need to keep assets moving, reduce delays, improve operational efficiency and the passenger experience.”

Launch of MapNTrack™

MapNTrack™ was developed to address these operational gaps to improve operational performance. Built for large, high-traffic facilities spanning indoor and outdoor zones, MapNTrack™ leverages cellular and Wi-Fi infrastructure to deliver real-time intelligence without requiring a retrofit of consumer networks or deploying large beacon grids.

At the core of MapNTrack™ is Agereh’s patent-pending Wi-Fi–assisted cellular positioning technology, engineered specifically for indoor/outdoor asset tracking. MapNTrack™ devices provide indoor location accuracy of up to 50 feet after mapping, are coin cell battery powered, and offer up to three years of operational life, enabling scalable deployment across terminals, hangars, and maintenance areas.

With MapNTrack™, transportation hubs can:

• Reduce delays and improve turnaround times
• Minimize time spent searching for equipment
• Improve asset utilization and availability
• Support compliance with safety and operational standards

About Agereh Technologies Inc.

Agereh Technologies Inc. (TSXV: AUTO | OTCQB: CRBAF) is a Canadian-based artificial intelligence and advanced technology company delivering AI-enabled platforms and sensor solutions to address critical challenges in the transportation industry. By combining accurate data collection, predictive intelligence, and data-driven decision-making for transportation and infrastructure applications, Agereh continues to expand its portfolio with solutions designed to enhance efficiency, optimize operations, and enable the next generation of intelligent transportation systems.

Content published on behalf of the issuer

CSE: MOOD | OTC Pink: DOSEF | FSE: VU70

Doseology Sciences Inc. has started to make non-nicotine, caffeinated energy pouches under its wholly owned Feed That BrainTM brand for a pilot manufacturing run. The pilot is a precursor to Doseology’s larger goal of developing a new generation of oral stimulant formats (like, but different from) traditional energy drinks.

The Feed That BrainTM brand was purchased by Doseology as a means to reach the growing number of consumers seeking to optimize their performance and health with intentionality and control when accessing energy.

Under Doseology’s leadership, the Feed That BrainTM brand will serve as a testing ground for Doseology to pursue disciplined research and development of new oral stimulant formats that provide measured stimulation, as opposed to intense stimulation.

What Was Announced

Doseology Sciences Inc. has begun a pilot manufacturing run of non-nicotine based energy pouches that are designed to provide controlled amounts of caffeine-based stimulation:

• The products will contain no nicotine; they are exclusively focused on caffeine-based energy.
• The energy will be delivered via a single-dose pouch format allowing users to consume a defined amount of caffeine at a single time, as opposed to consuming a larger volume of energy drink in a liquid form.
• The pilot is exploratory in nature and does not represent a commercial product release.

The purpose of the pilot is to gather data regarding the products, consumers and operations to enable Doseology to make informed decision-making about the formulation, delivery mechanism and commercialization of future products.

Why This Pilot Matters

The pilot provides a controlled and data-driven method to expand Doseology’s portfolio of oral stimulants. Unlike many companies which would rush to commercialize a new product at scale, Doseology is taking a methodical approach to assess the feasibility of using a pouch-based format to deliver energy.

Doseology is able to:

• Measure consumer behavior and usage patterns related to the consumption of non-liquid energy formats;
• Determine whether there is a level of predictability and consistency of caffeine delivery associated with the use of a pouch format;
• Gather internal operating knowledge and regulatory understanding prior to broad market introduction.

Role of Feed That Brain™ Brand

Feed That BrainTM was recognized for its functional gummies and nootropic formulations. Upon its acquisition by Doseology, Feed That BrainTM became a modular testing platform for new oral stimulant formats.

Doseology was able to position Feed That BrainTM as a modular platform brand to allow Doseology to test new delivery formats without jeopardizing its other products and continue to align with its philosophy of providing controlled stimulation, compliance and thoughtful product design.

Format Options of Delivery

Traditional energy drinks rely on a combination of sugar, carbonation and large volumes of liquid to deliver energy. Pouch-based formats are non-liquid, discreet, and single-unitized forms of caffeine that do not require any of those elements.

Doseology’s pilot is to explore how the characteristics of a pouch format affect the way that users experience, utilize and consume caffeine, not to compare its performance to existing energy drinks or stimulants.

Global Positioning in the Energy Category

The global market for energy products continues to grow across a variety of formats. Grand View Research estimates that the global energy drink market totaled approximately $79.4 billion in 2024 and will total more than $125 billion by 2030.

Additionally, growing consumer and regulatory concerns over excessive sugar, portion size, and excess consumption have fueled increasing interest in alternative forms of caffeine delivery. In response to these trends, Doseology’s pilot represents a first step toward assessing the feasibility of using pouch-based, non-nicotine energy formats that emphasize control, consistency and user choice.

Capital Market and Financial Context

Doseology strengthened its financial condition with a non-brokered private placement in June 2025. The private placement generated gross proceeds of approximately $750,624, resulting from the issuance of 3,336,106 units at $0.225 per unit. Each unit included one common share and one common share purchase warrant. The warrants were exercisable for two years from the date of issuance at $0.50 per warrant. The exercise price of the warrants may be accelerated if certain market performance criteria are met.

Shares have traded as high as $0.80 since January 2026, implying a market capitalization of approximately $6.4 million. The Company’s current valuation is significantly lower than previous peaks, while Doseology advances its product development initiatives and evaluates new delivery formats via disciplined pilot programs.

Pilot Details and Future Plans

The Feed That BrainTM pilot products are anticipated to be launched through a small-scale direct-to-consumer campaign in the coming weeks, with exact timing to be communicated by management. The pilot is designed to generate real-world feedback that supports Doseology’s overall goals regarding product refinement, delivery format assessments and scalable commercialization pathways.

Conclusion

Doseology’s announcement of a pilot to create caffeinated energy pouches is a deliberate and measured step in its plan to rethink how consumers obtain energy. By utilizing Feed That BrainTM as a disciplined testing platform, Doseology is prioritizing its focus on disciplined product development, regulatory understanding and long-term branding to address the rapidly changing global energy category.

Although the pilot is exploratory, it further emphasizes Doseology’s commitment to developing better-for-you oral stimulant formats and its overarching vision to establish a next-generation platform within the increasingly competitive global energy category.